Latest Breaking News On - Clinical asset development at abbvie inc - Page 1 : comparemela.com

Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today announced that

United kingdomMassachusetts institute of technologyUnited statesHelen ogormanRobert stanislaroWalden biosciencesBlaine mckeeWalden biosciences senior leadership teamStanford university school of medicineClinical asset development at abbvie incWalden biosciences incJohnson incClinical researchUniversity of pennsylvania medical centerTriaxis medical devices incResearch at acceleron pharma inc